Aehr Test Systems provides annual (not quarterly) revenue guidance, typically issued at Q4 earnings and updated throughout the year. Guidance often uses floor language (“at least $X”) rather than ranges. Verdicts use initial guidance for each fiscal year: Exceeded = actual above guidance high; Met = within range; Not Met = below guidance low. FY2024 initial guidance was dramatically revised down twice due to EV/SiC market softness. FY2025 guidance was withdrawn in Q3 due to tariff uncertainty. Quarterly bookings (new orders) are a critical leading indicator and are tracked separately below. GAAP EPS for Q4 FY2024 includes a $20.8M tax valuation allowance release.
Initial guidance issued at Q4 earnings of prior fiscal year. “At least $X” treated as guideLow = guideHigh = $X.
| Fiscal Year | Date Issued | Initial Guidance | Guide Low | Guide High | Actual Revenue | Δ vs Mid | Verdict | Notes | Source |
|---|
New orders received each quarter. Bookings are a critical leading indicator for future revenue. Book-to-bill >1.0x indicates growing backlog.
| Quarter | Period Ended | New Bookings ($M) | Book-to-Bill | Backlog ($M) | Eff. Backlog ($M) | Source |
|---|
From 8-K press releases. Non-GAAP EPS available from FY2024 onward.
| Quarter | Period Ended | Revenue ($M) | GAAP EPS ($) | Non-GAAP EPS ($) | Source |
|---|